Condition: Bipolar Disorder · Cognitive Impairment · Age-related Cognitive Decline · Sponsor: Groupe Hospitalier de la Rochelle Ré Aunis
Age is a major risk factor for the development of cognitive disorders and neurodegenerative pathologies. Cognitive disorders during the phases of bipolar disease are known to exist, and alterations increase significantly after the age of 65. Drug treatments seem to have only a limited effect. A cognitive stimulation program has proven his benefit to patients over 65 with neurodegenerative diseases (Israel, 2004). We propose to evaluate this cognitive stimulation program that we have adapted to bipolar disease.
This description comes directly from the study's public registry record.
Caroline ALLIX-BEGUEC, Ph.D. · +33 (0) 516 49 42 46 · caroline.allix-beguec@ght-atlantique17.fr
Always discuss trial participation with your own doctor first.
| Groupe Hospitalier de la Rochelle Ré Aunis | La Rochelle, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04184375